NCT04162873 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Collection of adverse events began on the first dose of study medication until the end of treatment visit (or until a new cancer treatment is initiated). Adverse events were collected for up to 5 months.
- Other-event reporting threshold
- 0%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Celecoxib Arm | 2 / 5 | 5 / 5 | 0 / 5 |
| Placebo Arm | 1 / 7 | 7 / 7 | 0 / 7 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Vascular disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Hypotension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Injury, poisoning and procedural complications - Other, specify
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- term
- Postoperative hemorrhage
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Syncope
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Vascular disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Thromboembolic event
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Wound dehiscence
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- term
- Abdominal distension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Immune system disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Allergic reaction
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 5
- num Events
- 5
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 7
- num Events
- 3
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 7
- num Events
- 2
- term
- Anorexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Anxiety
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Bone pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- term
- Bruising
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 5
- num Events
- 4
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- term
- Creatinine increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Depression
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 7
- num Events
- 2
- term
- Dermatitis radiation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 5
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Diarrhea
Complete source fields
- event Groups
- deaths Num Affected
- 0
- deaths Num At Risk
- 5
- description
- Patients received celecoxib PO or via feeding tube BID starting 1 to 7 days prior to surgery and continued until the completion of radiation therapy (up to 6 months in total) in the absence of disease progression or unacceptable toxicity. Celecoxib: Given PO or via feeding tube Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
- id
- EG000
- other Num Affected
- 5
- other Num At Risk
- 5
- serious Num Affected
- 2
- serious Num At Risk
- 5
- title
- Celecoxib Arm
- deaths Num Affected
- 0
- deaths Num At Risk
- 7
- description
- Patients received placebo PO or via feeding tube BID starting 1 to 7 days prior to surgery and continued until the completion of radiation therapy (up to 6 months in total) in the absence of disease progression or unacceptable toxicity. Placebo: Given PO or via feeding tube Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
- id
- EG001
- other Num Affected
- 7
- other Num At Risk
- 7
- serious Num Affected
- 1
- serious Num At Risk
- 7
- title
- Placebo Arm
- frequency Threshold
- 0
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- term
- Abdominal distension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Immune system disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Allergic reaction
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 5
- num Events
- 5
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 7
- num Events
- 3
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 7
- num Events
- 2
- term
- Anorexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Anxiety
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Bone pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- term
- Bruising
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 5
- num Events
- 4
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- term
- Creatinine increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Depression
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 7
- num Events
- 2
- term
- Dermatitis radiation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 5
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Diarrhea
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Vascular disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Hypotension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Injury, poisoning and procedural complications - Other, specify
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- term
- Postoperative hemorrhage
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Syncope
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Vascular disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Thromboembolic event
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- term
- Wound dehiscence
- time Frame
- Collection of adverse events began on the first dose of study medication until the end of treatment visit (or until a new cancer treatment is initiated). Adverse events were collected for up to 5 months.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle